CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Oxford BioMedica plc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Oxford BioMedica plc
Windrush Court,Transport Way
Phone: +44 1865783000p:+44 1865783000 OXFORD, OX4 6LT  United Kingdom Ticker: OXBOXB

Business Summary
Oxford Biomedica plc is a United Kingdom-based cell and gene therapy research, development and bio-processing company. The Company is engaged in providing services to third parties, as well as performing internal research and development for its own purposes. It performs a range of analytical assays within its in-house quality check (QC) labs. The Company operates through two segments: Platform and Product. Platform segment is involved in bio-processing and processes development activities undertaken process by third parties, which is the partner programme for LentiVector and AAV CDMOs business. The segment also includes internal technology developments and technical intellectual property within the LentiVector platform. Product segment consists of the clinical and pre-clinical development of in vivo and ex vivo cell and gene therapy products (gene therapeutics), which are owned by the Company.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/202312/31/2022Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Non-Executive Chairman of the Board Roch F.Doliveux 65 3/1/2023 6/24/2020
Chief Executive Officer, Executive Director FrankMathias 62 3/27/2023 3/27/2023
Non-Executive Vice Chairman of the Board, Independent Director StuartHenderson 3/27/2023 6/1/2016
12 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
ABL Europe S.A.S. 4 Rue Laurent Fries Illkirch-Graffenstaden France

Business Names
Business Name
ABL Biomanufacturing
ABL Europe S.A.S.
ABL, Inc.
5 additional Business Names available in full report.

General Information
Number of Employees: 891 (As of 6/30/2023)
Outstanding Shares: 99,957,395 (As of 1/29/2024)
Shareholders: 3,641
Stock Exchange: LON
Fax Number: +44 1865783001


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, March 28, 2024